Ascendis Pharma A (ASND) EBT Margin (QoQ) (2014 - 2026)
Ascendis Pharma A (ASND) EBT Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,312.00 |
| Dec 31, 2025 | 2,044.00 |
| Sep 30, 2025 | -471.00 |
| Jun 30, 2025 | 7,053.00 |
| Mar 31, 2025 | -8,062.00 |
| Dec 31, 2024 | 15,770.00 |
| Sep 30, 2024 | 13,345.00 |
| Jun 30, 2024 | -16,918.00 |
| Mar 31, 2024 | -10,724.00 |
| Dec 31, 2023 | 30,960.00 |
| Sep 30, 2023 | -7,925.00 |
| Jun 30, 2023 | 6,922.00 |
| Mar 31, 2023 | 55,625.00 |
| Dec 31, 2022 | 22,350.00 |
| Sep 30, 2022 | 21,478.00 |
| Jun 30, 2022 | 51,358.00 |
| Mar 31, 2022 | -171,119.00 |
| Dec 31, 2021 | 709,532.00 |
| Sep 30, 2021 | 593,620.00 |
| Jun 30, 2021 | -471,203.00 |